Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Analysis, 9(1):1-5
An integrated model of RAF inhibitor action predicts inhibitor activity against oncogenic BRAF signaling
Coagulation or precipitation of Fe 3+ ions did not occur because of low concentration of FeSO 4 (Dutta et al
Read the full POV: #OmnicomHealth #Archbow #UniquelyPowerful #TogetherUnstoppable #HealthcareAccess #ThoughtLeadership #TheNextBigThing #Telemedicine #PatientJourney #MarketAccess To view or add a comment, sign in This is a big deal
Trialize's positioning targets research organizations that require functional DCT capabilities but lack the budget or technical resources to deploy enterprise-scale platforms from major commercial vendors, making it particularly relevant for community-based sites, investigator-initiated trial networks, and emerging biotech sponsors in early-phase development
US$ 29.70
US$ 24.27
US$ 20.85
US$ 25.21
